- Home
- KYMR vs MYRG Comparison
KYMR vs MYRG Comparison
Compare KYMR & MYRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- MYRG
- Stock Information
- Founded
- KYMR 2015
- MYRG 1891
- Country
- KYMR United States
- MYRG United States
- Employees
- KYMR N/A
- MYRG N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- MYRG Water Sewer Pipeline Comm & Power Line Construction
- Sector
- KYMR Health Care
- MYRG Industrials
- Exchange
- KYMR Nasdaq
- MYRG Nasdaq
- Market Cap
- KYMR 3.1B
- MYRG 2.9B
- IPO Year
- KYMR 2020
- MYRG N/A
- Fundamental
- Price
- KYMR $42.63
- MYRG $181.01
- Analyst Decision
- KYMR Strong Buy
- MYRG Buy
- Analyst Count
- KYMR 16
- MYRG 7
- Target Price
- KYMR $58.94
- MYRG $192.86
- AVG Volume (30 Days)
- KYMR 622.1K
- MYRG 199.5K
- Earning Date
- KYMR 08-11-2025
- MYRG 07-30-2025
- Dividend Yield
- KYMR N/A
- MYRG N/A
- EPS Growth
- KYMR N/A
- MYRG 63.05
- EPS
- KYMR N/A
- MYRG 4.77
- Revenue
- KYMR $44,711,000.00
- MYRG $3,451,783,000.00
- Revenue This Year
- KYMR $58.26
- MYRG $6.56
- Revenue Next Year
- KYMR N/A
- MYRG $6.14
- P/E Ratio
- KYMR N/A
- MYRG $37.98
- Revenue Growth
- KYMR N/A
- MYRG N/A
- 52 Week Low
- KYMR $19.45
- MYRG $86.60
- 52 Week High
- KYMR $53.27
- MYRG $220.02
- Technical
- Relative Strength Index (RSI)
- KYMR 49.94
- MYRG 43.49
- Support Level
- KYMR $36.65
- MYRG $181.11
- Resistance Level
- KYMR $44.94
- MYRG $195.86
- Average True Range (ATR)
- KYMR 1.64
- MYRG 8.33
- MACD
- KYMR -0.18
- MYRG -1.77
- Stochastic Oscillator
- KYMR 72.14
- MYRG 8.98
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About MYRG MYR Group Inc.
MYR Group Inc is a U.S.-based holding company that provides specialty electrical construction services through its subsidiaries. The company operates through two segments. The transmission and distribution segment provides designing, engineering, procurement, construction, upgrade, maintenance, and repair services on transmission and distribution networks and substation facilities. The commercial and industrial segment provides services such as the design, installation, maintenance, and repair of commercial and industrial wiring, installation of traffic networks, and the installation of bridges. MYR Group generates the majority of its sales from the United States and Canada.